Clinical Trial Update: Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study [Phase 3]

View source ↗

Summary

Phase 3 pharmacokinetic study of inhaled liposomal amphotericin B (Ambisome) in lung transplant recipients with fungal infections has completed. The trial asses…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infections
• Lung Transplantation

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)

Snippet

Sponsor: University of Pittsburgh | Conditions: Lung Transplantation, Fungal Infections | Phase 3 | Status: COMPLETED